ICY:FRA
Incyte
101,10 €
arrow_downward
−0,44%(−0,45) 1 D
6. okt., 22:00:00 GMT+2 · EUR
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for ICY …
Ã…pne
101,05 €
Høy
101,10 €
Lav
101,05 €
Markedsverdi
23,08Â mrd.
Snittvolum
25,00
Volum
100,00
52 u høy
115,40 €
52Â u lav
72,28 €
Antall ansatte
3k
Ã…pne
101,05 €
Høy
101,10 €
Lav
101,05 €
Markedsverdi
23,08Â mrd.
Snittvolum
25,00
Volum
100,00
52 u høy
115,40 €
52Â u lav
72,28 €
Antall ansatte
3k
Nyhetssaker
Fra nettkilder og nyhetspartnere
AD HOC NEWS
·
for 55 minutter siden
Stifel raises target for Incyte stock to USD 157
MarketWatch
·
for 3 timer siden
Incyte Corp. stock underperforms Tuesday when compared to competitors
AD HOC NEWS
·
for 12 timer siden
Incyte stock gets a USD 157 Stifel price target after pipeline update
AD HOC NEWS
·
for 1 døgn siden
Incyte stock after-hours at EUR 100.70: minus 1.71 percent
Profil
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Om Incyte
Administrerende direktør-
Ansatte2,84k
Grunnlagt2002
HovedkontorWilmington, Delaware, USA
Sektor-
Nettstedincyte.com